Literature DB >> 7535742

Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations.

A Bonizzato1, L Bisceglia, C Marigo, E Nicolis, C Bombieri, C Castellani, G Borgo, L Zelante, G Mastella, G Cabrini.   

Abstract

A complete coding-region analysis on 225 cystic fibrosis (CF) chromosomes from a cohort that includes all the affected subjects born in two North-Eastern Italian regions over eight years was performed. In a previous study, we identified mutations on 166/225 (73.8%) CF chromosomes after screening for 62 mutations. To characterise the remaining 59 CF chromosomes, we carried out automated direct DNA sequencing (exons 9 and 13), RNA single-strand conformation polymorphism (exons 1-8 and 10-12) and denaturing gradient gel electrophoresis (exons 14a-24) of the 27 exons and flanking regions of the CF transmembrane conductance regulator gene. We identified 22 mutations, four of which are novel, viz. 711 + 5G-->A, R709X, 3132delTG and 2790-2A-->G, and we characterised 90.2% (203/225) of the CF chromosomes. Taking advantage of the homogeneity of the sample, an evaluation of the most important clinical parameters, assessed at the age of 12 years, is presented. We confirm some previously reported genotype-phenotype correlations and we report a new nonsense mutation (R709X) associated with a pancreatic sufficient phenotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535742     DOI: 10.1007/bf00208963

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  35 in total

1.  Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations.

Authors:  P Gasparini; A Bonizzato; M Dognini; P F Pignatti
Journal:  Mol Cell Probes       Date:  1992-02       Impact factor: 2.365

2.  The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences.

Authors:  P Gasparini; V Nunes; A Savoia; M Dognini; N Morral; A Gaona; A Bonizzato; M Chillon; F Sangiuolo; G Novelli
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

3.  Identification of six novel mutations in the CFTR gene of patients from Bulgaria by screening the twenty seven exons and exon/intron boundaries using DGGE and direct DNA sequencing.

Authors:  A Savov; B Mercier; L Kalaydjieva; C Férec
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

4.  Direct sequencing of the complete CFTR gene: the molecular characterisation of 99.5% of CF chromosomes in Wales.

Authors:  J P Cheadle; M C Goodchild; A L Meredith
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

5.  Prevalence of cystic fibrosis mutations in the Grampian region of Scotland.

Authors:  Z H Miedzybrodzka; J C Dean; G Russell; J A Friend; K F Kelly; N E Haites
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

6.  DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory.

Authors:  S G Fischer; L S Lerman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis.

Authors:  M Vidaud; P Fanen; J Martin; N Ghanem; S Nicolas; M Goossens
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

8.  Identification of the M1101K mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and complete detection of cystic fibrosis mutations in the Hutterite population.

Authors:  J Zielenski; T M Fujiwara; D Markiewicz; A J Paradis; A I Anacleto; B Richards; R H Schwartz; K W Klinger; L C Tsui; K Morgan
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

9.  Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation.

Authors:  A Augarten; B S Kerem; Y Yahav; S Noiman; Y Rivlin; A Tal; H Blau; L Ben-Tur; A Szeinberg; E Kerem
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

10.  Genetic determination of exocrine pancreatic function in cystic fibrosis.

Authors:  P Kristidis; D Bozon; M Corey; D Markiewicz; J Rommens; L C Tsui; P Durie
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

View more
  11 in total

1.  Thirteen cystic fibrosis patients, 12 compound heterozygous and one homozygous for the missense mutation G85E: a pancreatic sufficiency/insufficiency mutation with variable clinical presentation.

Authors:  C Vazquez; G Antiñolo; T Casals; J Dapena; J Elorz; J L Seculi; J Sirvent; R Cabanas; C Soler; X Estivill
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

2.  CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test.

Authors:  C Castellani; A Bonizzato; G Mastella
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

3.  The use of DHPLC (Denaturing High Performance Liquid Chromatography) in II level screening of the CFTR gene in Prenatal Diagnosis.

Authors:  Alvaro Mesoraca; Manuela Di Natale; Antonella Cima; Gianluca Di Giacomo; Monica Sarti; Maria Antonietta Barone; Domenico Bizzoco; Pietro Cignini; Luisa Mobili; Laura Dʼemidio; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2010-07

4.  Prenatal screening of Cystic Fibrosis: a single centre experience.

Authors:  Domenico Bizzoco; Alvaro Mesoraca; Antonella Cima; Monica Sarti; Gianluca Di Giacomo; Giovanna Scerra; Maria Antonietta Barone; Manuela Di Natale; Ivan Gabrielli; Caterina Tamburino; Claudia Scargiali; Cristina Ernandez; Maria Pia D'Aleo; Michele Todini; Rita Pompili; Luisa Mobili; Lucia Mangiafico; Ornella Carcioppolo; Claudio Coco; Pietro Cignini; Laura D'Emidio; Alessandra Girgenti; Cristiana Brizzi; Alessandro Cavaliere; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2008-01

5.  Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure.

Authors:  G Castaldo; E Rippa; G Sebastio; V Raia; P Ercolini; G de Ritis; D Salvatore; F Salvatore
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

6.  A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype.

Authors:  Jérôme Clain; Jacqueline Lehmann-Che; Emmanuelle Girodon; Joanna Lipecka; Aleksander Edelman; Michel Goossens; Pascale Fanen
Journal:  Hum Genet       Date:  2005-03-03       Impact factor: 4.132

7.  Clinical features of cystic fibrosis patients with rare genotypes.

Authors:  G Castaldo; E Rippa; V Raia; D Salvatore; C Massa; G de Ritis; F Salvatore
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

8.  Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening.

Authors:  Marco Cipolli; Carlo Castellani; Bridget Wilcken; John Massie; Karen McKay; Margie Gruca; Anna Tamanini; Maurice Baroukh Assael; Kevin Gaskin
Journal:  Arch Dis Child       Date:  2007-04-20       Impact factor: 3.791

9.  Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.

Authors:  Maria Rosaria D'Apice; Stefano Gambardella; Mario Bengala; Silvia Russo; Anna Maria Nardone; Vincenzina Lucidi; Federica Sangiuolo; Giuseppe Novelli
Journal:  BMC Med Genet       Date:  2004-04-14       Impact factor: 2.103

10.  Early diagnosis from newborn screening maximises survival in severe cystic fibrosis.

Authors:  Gloria Tridello; Carlo Castellani; Ilaria Meneghelli; Anna Tamanini; Baroukh M Assael
Journal:  ERJ Open Res       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.